Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Essential requirement for polypyrimidine tract binding proteins 1 and 3 in the maturation and maintenance of mature B cells in mice.

Monzón-Casanova E. et al, (2021), Eur J Immunol, 51, 2266 - 2273

RNA Binding Proteins As Regulators of Oxidative Stress Identified by a Targeted CRISPR-Cas9 Single Guide RNA Library.

Turner DJ. and Turner M., (2021), The CRISPR journal, 4, 427 - 437

Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers

Vahsen BF. et al, (2021), Nature Reviews Neurology, 17, 333 - 348

Isolated homozygous R217X OPTN mutation causes knock-out of functional C-terminal optineurin domains and associated oligodendrogliopathy-dominant ALS–TDP

Nolan M. et al, (2021), Journal of Neurology, Neurosurgery & Psychiatry

To Zoom or Not to Zoom: The Should I Travel Index Revisited during the Coronavirus Disease Pandemic

Rutkove SB. et al, (2021), Annals of Neurology

Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

Dewan R. et al, (2021), Neuron, 109, 448 - 460.e4

Efficient homing of antibody-secreting cells to the bone marrow requires RNA-binding protein ZFP36L1

Saveliev A. et al, (2021), Journal of Experimental Medicine, 218

Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study.

Ross Russell AL. et al, (2021), Brain Commun, 3

Improving clinical trial outcomes in amyotrophic lateral sclerosis.

Kiernan MC. et al, (2020), Nat Rev Neurol

Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP

FENEBERG E. et al, (2020), Brain Pathology

Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: A multicenter study

Steinacker P. et al, (2020), Amyotrophic lateral sclerosis & frontotemporal degeneration

CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis

Thompson AG. et al, (2020), Clinical Proteomics, 17

Value of systematic genetic screening of patients with amyotrophic lateral sclerosis

Shepheard SR. et al, (2020), Journal of Neurology, Neurosurgery and Psychiatry

Characterising neuropsychiatric disorders in patients with COVID-19 - Authors' reply.

Varatharaj A. et al, (2020), Lancet Psychiatry, 7, 934 - 935

Methods for quantitative susceptibility and R2* mapping in whole post-mortem brains at 7T applied to amyotrophic lateral sclerosis

Wang C. et al, (2020), NeuroImage, 222, 117216 - 117216

Neuroimaging in primary lateral sclerosis

Pioro E. et al, (2020), Amyotrophic lateral sclerosis & frontotemporal degeneration

An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress

Feneberg E. et al, (2020), Neurobiology of Disease, 144, 105050 - 105050

Grand rounds: a precious resource to be nurtured

Ross Russell AL. et al, (2020), Practical Neurology, 20, 342 - 344

Amyotrophic lateral sclerosis with a heterozygous D91A SOD1 variant and classical ALS-TDP neuropathology

Feneberg E. et al, (2020), Neurology, 95, 595 - 596

Neurophysiological features of primary lateral sclerosis

de Carvalho M. et al, (2020), Amyotrophic lateral sclerosis & frontotemporal degeneration

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?